| Date Filed | Type | Description |
| 06/28/2023 |
4
| Bray June (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Granted 17,000 options to buy
@ $17.52, valued at
$297.8k
|
|
| 06/28/2023 |
4
| MUELLER PETER (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Granted 17,000 options to buy
@ $17.52, valued at
$297.8k
|
|
| 06/28/2023 |
4
| MILLER MICHAEL PATRICK (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Granted 17,000 options to buy
@ $17.52, valued at
$297.8k
|
|
| 06/28/2023 |
4
| Laumas Sandeep (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Granted 17,000 options to buy
@ $17.52, valued at
$297.8k
|
|
| 06/28/2023 |
4
| Votruba Michal (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Granted 17,000 options to buy
@ $17.52, valued at
$297.8k
Disposed of 17,000 options to buy
@ $17.52, valued at
$297.8k
|
|
| 06/16/2023 |
4
| Rodriguez Javier (See Remarks) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Exercised 521 restricted stock units
@ $0 |
|
| 06/16/2023 |
4
| Yocca Frank (Chief Scientific Officer) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Exercised 521 restricted stock units
@ $0 |
|
| 06/16/2023 |
4
| Steinhart Richard I (CFO) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Exercised 521 restricted stock units
@ $0 |
|
| 06/16/2023 |
4
| Mehta Vimal (CEO and President) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Sold 21,988 shares
@ $21.41, valued at
$470.8k
Sold 8,012 shares
@ $21.9, valued at
$175.5k
Sold 24,987 shares
@ $20.01, valued at
$500k
Sold 4,266 shares
@ $20.9, valued at
$89.2k
Sold 747 shares
@ $21.89, valued at
$16.4k
Exercised 2,609 restricted stock units
@ $0
Exercised 30,000 options to buy
@ $0.41, valued at
$12.3k
Exercised 30,000 options to buy
@ $0.41, valued at
$12.3k
|
|
| 06/16/2023 |
4
| O'Neill Vincent (Chief Medical Officer) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Exercised 521 restricted stock units
@ $0 |
|
| 05/24/2023 |
4
| Mehta Vimal (CEO and President) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Sold 6,500 shares
@ $25.7909, valued at
$167.6k
|
|
| 05/16/2023 |
4
| Mehta Vimal (CEO and President) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Exercised 15,000 restricted stock units
@ $0 |
|
| 05/16/2023 |
4
| Steinhart Richard I (CFO) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $27.1727, valued at
$135.9k
Exercised 5,000 restricted stock units
@ $0 |
|
| 05/16/2023 |
4
| Rodriguez Javier (See Remarks) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Sold 1,785 shares
@ $27.3192, valued at
$48.8k
Exercised 5,000 restricted stock units
@ $0 |
|
| 04/14/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/22/2023 |
4
| Mehta Vimal (CEO and President) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Sold 24,667 shares
@ $18.2, valued at
$448.9k
Sold 5,333 shares
@ $18.86, valued at
$100.6k
Sold 3,896 shares
@ $18.22, valued at
$71k
Sold 604 shares
@ $18.88, valued at
$11.4k
Sold 29,100 shares
@ $19.7, valued at
$573.3k
Sold 900 shares
@ $20.15, valued at
$18.1k
Exercised 30,000 options to buy
@ $0.41, valued at
$12.3k
Exercised 30,000 options to buy
@ $0.41, valued at
$12.3k
|
|
| 03/16/2023 |
4
| Steinhart Richard I (CFO) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Sold 2,084 shares
@ $19.5, valued at
$40.6k
Exercised 2,084 restricted stock units
@ $0
Granted 9,000 restricted stock units
@ $0
Granted 32,000 options to buy
@ $19.6, valued at
$627.2k
|
|
| 03/16/2023 |
4
| Yocca Frank (Chief Scientific Officer) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Sold 985 shares
@ $19.6911, valued at
$19.4k
Exercised 2,084 restricted stock units
@ $0
Granted 9,000 restricted stock units
@ $0
Granted 32,000 options to buy
@ $19.6, valued at
$627.2k
|
|
| 03/16/2023 |
4
| Mehta Vimal (CEO and President) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Exercised 10,437 restricted stock units
@ $0
Granted 56,000 restricted stock units
@ $0
Granted 168,000 options to buy
@ $19.6, valued at
$3.3M
|
|
| 03/16/2023 |
4
| O'Neill Vincent (Chief Medical Officer) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Sold 845 shares
@ $19.695, valued at
$16.6k
Exercised 2,084 restricted stock units
@ $0
Granted 9,000 restricted stock units
@ $0
Granted 32,000 options to buy
@ $19.6, valued at
$627.2k
|
|
|